Medication AdherenceNCT01755312
The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes
A study testing Medication reminder in people with Medication Adherence and Blood Pressure, run by Purdue University at 1 site in United States.
Trial summary
This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Medication Adherence, Blood Pressure
- What is being tested?
- Medication reminder
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 28 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2013to Jan 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- poor medication adherence
- high blood pressure
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Medication Reminder Technology on Medication Adherence and Hypertension
This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed
- Conditions
- Medication Adherence, Blood Pressure
- Being tested
- Medication reminder
- Medical subject headings
- Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medication reminderDevice
Medication reminder
| Study group | Role | What they receive |
|---|---|---|
| medication reminder | Experimental | medication reminder Receives: Device: Medication reminder |
| Placebo | Placebo comparator | Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool
Measured: 6 months
Secondary outcomes (1)
systolic blood pressure in mmHg using a valid automated device
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Dec 2012 (estimated)
- Study startJun 2013
- Primary completionJan 2015
- Study completionJan 2015
Why it stopped: Research site no longer available
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medication AdherenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- Purdue University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alan Zillich Lab, Purdue University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01755312
- Sponsor's protocol ID
- 2r44ago39178-02 (1208012596)
- Status last verified
- Aug 2015
- First submitted
- 18 Dec 2012
- Last updated
- 27 Aug 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Aug 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Medication Reminder Technology on Medication Adherence and Hypertension
- ClinicalTrials.gov ID
- NCT01755312
- Acronym / sponsor ID
- 2r44ago39178-02 (1208012596)
- Conditions
- Medication Adherence, Blood Pressure
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Research site no longer available
- Enrolment
- 28 participants (actual)
- Lead sponsor
- Purdue UniversityUniversity, hospital or other
- Study start
- Jun 2013
- Primary completion
- Jan 2015 (actual)
- Study completion
- Jan 2015 (actual)
- First posted
- 24 Dec 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study to evaluates how a med reminder affects the patient's ability to take medications as prescribed
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| medication reminder | Experimental | Device: Medication remindermedication reminder |
| Placebo | Placebo comparator | –Placebo |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- poor medication adherence
- high blood pressure
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medication reminderMedication reminder | Device | medication reminder |
Primary outcome
self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool
Time frame: 6 months
1 secondary outcome
systolic blood pressure in mmHg using a valid automated device
Time frame: 6 months
Results and safety
The study was stopped early (reason given: Research site no longer available). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Aug 2015.
Related trials for Medication Adherence
Not yet recruiting
Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition
Hypertension, Diabetes Mellitus, Type 2
Not yet recruiting
A Nurse-Led Personalized Self-Management Counseling Intervention to Improve Medication Adherence and Glycemic Control in Adults With Type 2 Diabetes: A Randomized Controlled Trial
Medication Adherence, Glycemic Control for Diabetes Mellitus
Not yet recruiting
Assessing Psoriasis Treatment Outcomes
Psoriasis
Active, not recruiting
HERDA: Pharmacist-Led Culturally Adapted Intervention for Depression Medication Adherence
Depression
Not yet recruiting
Asthma Ctrl SMART Trial
Asthma in Children, Asthma Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Medication reminder in people with Medication Adherence and Blood Pressure, run by Purdue University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 27 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Research site no longer available). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
self-reported medication adherence using the Morisky 8-Item Medication Adherence Scale(MMAS-8) tool (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2015.